| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |